NCT02780804 2023-10-17Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed21 enrolled 15 charts
NCT01383447 2017-08-08Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Terminated2 enrolled 4 charts